Professor of Biochemistry, Biophysics and Structural Biology Jennifer Doudna has been named a foreign member of the prestigious Royal Society, a rare honor for a UC Berkeley faculty member. She joins MCB Professors John Kuriyan and Randy Schekman as elected foreign members of the society, and Professors G. Steven Martin and Gerald Westheimer, who are fellows within the society.
Below are articles from various sources about members of MCB and their research.
Professor of the Graduate School Jack Kirsch has received the presitigious UC Berkeley Edward A. Dickson Emeriti Professorship in recognition of his exemplary continued service in teaching, research, and public service.
Professor Emeritus of Neurobiology Walter J. Freeman passed away at age 89 in Berkeley on Sunday, April 24, 2016. He was a UC Berkeley professor for nearly 60 years, and is considered one of the founders of the field of computational neuroscience.
Howard Hughes Medical Institute Investigator and Professor of Biochemistry, Biophysics and Structural Biology Eva Nogales and Professor Emeritus of Biochemistry, Biophysics and Structural Biology Robert Glaeser are among nine UC Berkeley faculty members newly elected to the American Academy of Arts and Sciences.
Assistant Professor of Genetics, Genomics and Development Hernan Garcia is one of 15 scientists named as 2016 Searle Scholars. The exceptional young scientists are selected for their potential to make significant contributions to chemical and biological research over the course of their careers.
Associate Adjunct Professor of Genetics, Genomics and Development Fyodor Urnov's career is featured in the April edition of ASBMB Today. His current endeavors target the inherited blood diseases beta-thalassemia and sickle-cell, offering alternatives to current treatments through gene editing, while still inspiring Berkeley undergraduates.
"MCB cancer immunologists are teaming up with colleagues working on infectious disease to create a new Immunotherapeutics and Vaccine Research Initiative, fueled by $7.5 million in funding from Aduro Biotech Inc., a Berkeley company that develops immunotherapies for cancer and other diseases."